Abstract
Funding for this monograph has been provided through an unrestricted educational grant from Novartis Oncology. Sponsorship of this monograph does not imply the sponsor's agreement with the views expressed herein. Every effort has been made to ensure that drug usage and other information are presented accurately; however, the ultimate responsibility rests with the prescribing physician. ERS, Akita Biomedical Consulting and its editorial staff, Cancer Control Journal, and Alan F. List, MD, shall not be held responsible for errors or for any consequences arising from the use of information contained herein. Readers are strongly urged to consult any relevant primary literature. No claims or endorsements are made for any drug or compound at present under clinical investigation.